(Q33693084)

28 July 2017

Efficacy of LY333328 against experimental methicillin-resistant Staphylococcus aureus endocarditis (English)

1 reference

methicillin-resistant Staphylococcus aureus

28 July 2017

0 references

Staphylococcus aureus

1 reference

G W Kaatz

1

1 reference

28 July 2017

S M Seo

2

1 reference

28 July 2017

J R Aeschlimann

3

1 reference

28 July 2017

H H Houlihan

4

1 reference

28 July 2017

R C Mercier

5

1 reference

28 July 2017

M J Rybak

6

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

Antimicrobial Agents and Chemotherapy

28 July 2017

3

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

28 July 2017

42

1 reference

28 July 2017

981-983

1 reference

28 July 2017

4

1 reference

Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faecium

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105587

In vitro activity and spectrum of LY333328, a novel glycopeptide derivative.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105587

In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105587

Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105587

Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105587

Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105587

Automated fluorescence polarization immunoassay for monitoring vancomycin.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105587

Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105587

Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105587

Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105587

Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105587

Time-kill curves for a semisynthetic glycopeptide, LY333328, against vancomycin-susceptible and vancomycin-resistant Enterococcus faecium strains.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105587

Determination of vancomycin related substances by gradient high-performance liquid chromatography

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9559828

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Reduced susceptibility of Staphylococcus aureus to vancomycin--Japan, 1996

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9559828

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

PMCID

105587

1 reference

28 July 2017

1 reference